Zobrazeno 1 - 10
of 225
pro vyhledávání: '"egon stenager"'
Autor:
Nete Munk Nielsen, Thor Grønborg Junker, Arieh S. Cohen, Kassandra L. Munger, Egon Stenager, Alberto Ascherio, Lasse Boding, Anders Hviid
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract We explored the association between COVID-19 severity and vitamin D status using information from Danish nation-wide health registers, the COVID-19 surveillance database and stored blood samples from the national biobank. 25-hydroxyvitamin D
Externí odkaz:
https://doaj.org/article/53418a9ecfe74609b071620deacd8351
Autor:
Nete Munk Nielsen, Thor Grønborg Junker, Sanne Grundvad Boelt, Arieh S. Cohen, Kassandra L. Munger, Egon Stenager, Alberto Ascherio, Lasse Boding, Anders Hviid
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/48565b124aa6407db87a661bf409aaf9
Autor:
Sepehr Mamoei, Henrik Boye Jensen, Andreas Kristian Pedersen, Mikkel Karl Emil Nygaard, Simon Fristed Eskildsen, Ulrik Dalgas, Egon Stenager
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Objective: Persons with multiple sclerosis (PwMS), already established as responders or non-responders to Fampridine treatment, were compared in terms of disability measures, physical and cognitive performance tests, neurophysiology, and magnetic res
Externí odkaz:
https://doaj.org/article/90a3582143a64ba8837cb90cfd1f6cf2
Autor:
Egon Stenager, Ulrik Dalgas, Morten Riemenschneider, Lars G Hvid, Steffen Ringgaard, Mikkel K E Nygaard, Simon F Eskildsen, Thor Petersen
Publikováno v:
BMJ Open, Vol 11, Iss 1 (2021)
Introduction In the relapsing remitting type of multiple sclerosis (MS) reducing relapses and neurodegeneration is crucial in halting the long-term impact of the disease. Medical disease-modifying treatments have proven effective, especially when int
Externí odkaz:
https://doaj.org/article/011de7348b2740fd8932e3b771f1658d
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 7 (2014)
This systematic review summarizes the existing evidence on the effect of 4-aminopyridine (4-AP) as a symptomatic treatment of decreased walking capacity in patients with multiple sclerosis (MS) when administered as an immediate release compound and a
Externí odkaz:
https://doaj.org/article/f82ce7d7ec494296bf71bac9804211d3
Autor:
Nasrin Asgari, Anne Voss, Troels Steenstrup, Kirsten Ohm Kyvik, Egon Stenager, Soeren Thue Lillevang
Publikováno v:
Clinical and Developmental Immunology, Vol 2013 (2013)
Interferon-alpha (IFN-α) has immunoregulatory functions in autoimmune inflammatory diseases. The goal of this study was to determine occurrence and clinical consequences of IFN-α in neuromyelitis optica (NMO) patients. Thirty-six NMO and 41 multipl
Externí odkaz:
https://doaj.org/article/27c61556277f4d88a5ed179fbc3cd514
Autor:
Ulrik Dalgas, Egon Stenager
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 5 (2012)
It has been suggested that exercise (or physical activity) might have the potential to have an impact on multiple sclerosis (MS) pathology and thereby slow down the disease process in MS patients. The objective of this literature review was to identi
Externí odkaz:
https://doaj.org/article/548f41be5c0c44d9bc8472455a91e74a
Autor:
Aslak Harbo Poulsen, Egon Stenager, Christoffer Johansen, Joan Bentzen, Søren Friis, Joachim Schüz
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e34453 (2012)
We investigated the risk of, prognosis of and symptoms of multiple sclerosis (MS) among all Danish residents who owned a mobile phone subscription before 1996. Using the Danish Multiple Sclerosis Registry and Civil Registration System, study subjects
Externí odkaz:
https://doaj.org/article/92be1023bcc24a3f96f0f5cdbcbe9065
Publikováno v:
Clinical Epidemiology. 15:375-389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c84b38de6f5e829bc2ce000124a3024
https://doi.org/10.2147/clep.s392273
https://doi.org/10.2147/clep.s392273
Publikováno v:
Riemenschneider, M, Hvid, L G, Petersen, T, Stenager, E & Dalgas, U 2023, ' Exercise Therapy in Early Multiple Sclerosis Improves Physical Function But Not Cognition : Secondary Analyses From a Randomized Controlled Trial ', Neurorehabilitation and Neural Repair, vol. 37, no. 5, pp. 288-297 . https://doi.org/10.1177/15459683231159659
Background Exercise positively affects multiple sclerosis (MS) symptoms, physiological systems, and potentially cognition. However, an uninvestigated “window of opportunity” exists for exercise therapy early in the disease. Objective This study p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e66e36efe8d0a01838a581f9f259911
https://pure.au.dk/portal/da/publications/exercise-therapy-in-early-multiple-sclerosis-improves-physical-function-but-not-cognition(ed21bfb6-1102-43cc-a793-23acba0cd036).html
https://pure.au.dk/portal/da/publications/exercise-therapy-in-early-multiple-sclerosis-improves-physical-function-but-not-cognition(ed21bfb6-1102-43cc-a793-23acba0cd036).html
